HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yael Flamand Selected Research

Transcription Factors (Transcription Factor)

1/2022The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yael Flamand Research Topics

Disease

8Neoplasms (Cancer)
01/2023 - 11/2014
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 01/2022
4Disease Progression
01/2023 - 11/2014
2Squamous Cell Carcinoma of Head and Neck
12/2023 - 01/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2023
1Lymphopenia (Lymphocytopenia)
11/2023
1Fatigue
11/2023
1Leukemia
10/2023
1Renal Cell Carcinoma (Grawitz Tumor)
01/2023
1Extranodal Extension
01/2023
1Carcinoma (Carcinomatosis)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2023
1Left Ventricular Dysfunction
01/2023
1Overweight
01/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022
1Vision Disorders (Hemeralopia)
10/2022
1Hemorrhage
10/2022
1Deglutition Disorders (Dysphagia)
10/2022
1Oropharyngeal Neoplasms
10/2022
1Disseminated Intravascular Coagulation
10/2022
1Pleural Effusion (Pleural Effusions)
03/2022
1Pancreatitis
03/2022
1Thrombosis (Thrombus)
01/2022
1Hyperglycemia
01/2022
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022
1Neutropenia
04/2015
1Sarcoma (Soft Tissue Sarcoma)
04/2015
1Anemia
11/2014
1Thrombocytopenia (Thrombopenia)
11/2014
1Ewing Sarcoma (Sarcoma, Ewing)
11/2014

Drug/Important Bio-Agent (IBA)

4Asparaginase (Elspar)FDA Link
01/2024 - 03/2022
1Bevacizumab (Avastin)FDA Link
12/2023
1PlatinumIBA
12/2023
1trametinibIBA
01/2023
1Sorafenib (BAY 43-9006)FDA Link
01/2023
1Sunitinib (Sutent)FDA Link
01/2023
1NucleotidesIBA
01/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023
1Estrogen Receptor alphaIBA
01/2023
1TNF Receptor-Associated Factor 3IBA
01/2023
1Retinaldehyde (Retinal)IBA
10/2022
1Dacarbazine (DIC)FDA LinkGeneric
10/2022
1antiarrhythmic peptide (AAP)IBA
03/2022
1Insulin (Novolin)FDA Link
01/2022
1Blood Group Antigens (Blood Groups)IBA
01/2022
1pegaspargase (Oncaspar)FDA Link
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022
1GlucocorticoidsIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2015
1Histone Deacetylase InhibitorsIBA
04/2015
1Histone Deacetylases (Histone Deacetylase)IBA
04/2015
1abexinostatIBA
04/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2014
1TabletsIBA
11/2014
1olaparibIBA
11/2014

Therapy/Procedure

9Therapeutics
11/2023 - 04/2015
5Drug Therapy (Chemotherapy)
12/2023 - 11/2014
2Induction Chemotherapy
10/2022 - 01/2022
1Blood Component Removal (Apheresis)
11/2023
1Precision Medicine
01/2023
1Radiotherapy
10/2022